Clinical Trial Update: To Explore the Efficacy of Sintilimab Combined With Bevacizumab in Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial registry entry evaluating the efficacy of combining sintilimab with bevacizumab in rectal cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Sintilimab (sintilimab)

Snippet

Sponsor: xiaohua li | Conditions: Rcctal Cancer | Phase 2 | Status: RECRUITING